<i>Panax ginseng</i> Inhibits Metabolism of Diester Alkaloids by Downregulating CYP3A4 Enzyme Activity via the Pregnane X Receptor

Abstract

To investigate the effects of <i>P. ginseng</i> C.A. Mey (<i>P. ginseng</i>) on the metabolism of diester alkaloids and explore the potential mechanism. P. ginseng was administered orally to rats for 7 days, after which liver microsome samples were prepared and then incubated with diester alkaloids. Ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry was used to determinate the concentration of diester alkaloids to calculate the clearance rate. The cocktail method was used to evaluate the effects of oral administration of <i>P. ginseng</i> extracts on the activities of cytochrome P450 (CYP) isoforms in rats through the changes in the pharmacokinetic parameters of the probe drugs. The protein and gene expression of CYP3A2 and pregnane X receptor (PXR) in rats were evaluated by western blotting and quantitative PCR. The specific enzyme inhibitor method and human recombinant enzyme method were used to identify the involvement of sub-CYPs in the metabolism of diester alkaloids in human liver microsomes (HLMs). The clearances of aconitine, mesaconitine, and hypaconitine in the <i>P. ginseng</i> groups were lower than those of the control group. The areas under the curve of midazolam were 2.37 ± 1.05, 4.96 ± 0.51, and 6.23 ± 1.30 mg·L^-1·h for the low-, medium-, and high-dose <i>P. ginseng</i> groups, respectively, which were higher than that of the control (2.23 ± 0.64 mg·L^-1·h). The clearances of midazolam for the medium- (1.87 ± 0.16 L·h^-1·kg^-1) and high-dose (1.60 ± 0.34 L·h^-1·kg^-1) <i>P. ginseng</i> groups were lower than that of the control group (4.66 ± 1.43 L·h^-1·kg^-1). After exposure to <i>P. ginseng</i> extracts, the gene and protein expression levels of CYP3A4 and PXR were decreased. The hepatic metabolism rates of aconitine, mesaconitine, and hypaconitine in HLMs were decreased to 60.37%, 21.67%, and 10.11%, respectively, when incubated with ketoconazole, a specific inhibitor for CYP3A. The kinetic plots indicated that the K_M and <i>V</i> _max values of CYP3A4 were 10.08 ± 3.26 <i>μ</i>M and 0.12 ± 0.01nmol·mg protein^-1·min^-1 for aconitine, 131.3 ± 99.75 <i>μ</i>M and 0.73 ± 0.44 nmol·mg protein^-1·min^-1 for mesaconitine, and 17.05 ± 9.70 <i>μ</i>M and 0.16 ± 0.04 nmol·mg protein^-1·min^-1 for hypaconitine, respectively. The in vitro mean intrinsic clearance rates by CYP3A4 were 0.0119, 0.0056, and 0.0091 mL·nmol CYP^-1·min^-1 for aconitine, mesaconitine, and hypaconitine, respectively. Therefore we implied that <i>P. ginseng</i> inhibited the metabolism of diester alkaloids in vitro and decreased the CYP3A4 enzyme activity as well as the gene and protein expression of CYP3A4 and PXR in vivo. CYP3A4 had a larger effect on diester alkaloid metabolism than the other human CYP isoforms, CYP1A2, CYP2C9, and CYP2E1.